Any primary pulmonary hypertension in which the cause of the disease is a mutation in the BMPR2 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Actelion Pharmaceuticals Ltd
Other
Altavant Sciences GmbH
Other
Bial-Portela & Cª., S.A.
Other
BioRamo, LLC
Other
Cadrenal Therapeutics
Other
CytRx Corporation
Other
GenThera, Inc.
Other
Glaxo Wellcome Inc.
Other
Veralox Therapeutics
Other
Zymedi Co., Ltd.
Other